These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39188588)

  • 1. Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China.
    Lin W; Wang K; Chen Y; Zheng Z; Lin Y
    Mol Genet Metab Rep; 2024 Sep; 40():101127. PubMed ID: 39188588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency in Zhejiang province, China.
    Cheng Y; Chen P; Yu Z; Yin X; Zhang C; Miao H; Huang X
    Clin Chim Acta; 2023 Mar; 542():117266. PubMed ID: 36822454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follow up and gene mutation analysis in cases suspected as 3-methylcrotonyl-coenzyme A carboxylase deficiency by neonatal screening].
    Ye J; Gong L; Han L; Qiu W; Zhang H; Gao X; Jin J; Xu H; Gu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):409-14. PubMed ID: 25190158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment.
    Stadler SC; Polanetz R; Maier EM; Heidenreich SC; Niederer B; Mayerhofer PU; Lagler F; Koch HG; Santer R; Fletcher JM; Ranieri E; Das AM; Spiekerkötter U; Schwab KO; Pötzsch S; Marquardt I; Hennermann JB; Knerr I; Mercimek-Mahmutoglu S; Kohlschmidt N; Liebl B; Fingerhut R; Olgemöller B; Muntau AC; Roscher AA; Röschinger W
    Hum Mutat; 2006 Aug; 27(8):748-59. PubMed ID: 16835865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary?
    Wang H; Liu S; Wang B; Yang Y; Yu B; Wang L; Wang T
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1321-1326. PubMed ID: 31730530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and genetic features of children with 3-methylcrotonyl-coenzyme A carboxylase deficiency: an analysis of six cases].
    Zhang LM; Wu SN; Guo YN; Yang JW; Sun HQ; Yang JM; Chen YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug; 26(8):845-851. PubMed ID: 39148390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An asymptomatic father diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency following his son newborn screening test.
    Terracciano R; Ruoppolo M; Barretta F; Albano L; Crisci D; Gallo G; Uomo F; Strisciuglio P; Parenti G; Frisso G; Rossi A
    Mol Genet Metab Rep; 2024 Sep; 40():101116. PubMed ID: 39055105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and molecular characterization of 3-Methylcrotonylglycinuria in an Italian asymptomatic girl.
    Cozzolino C; Villani GR; Frisso G; Scolamiero E; Albano L; Gallo G; Romanelli R; Ruoppolo M
    Genet Mol Biol; 2018 Apr./Jun; 41(2):379-385. PubMed ID: 29767664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is L-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency?
    Thomsen JA; Lund AM; Olesen JH; Mohr M; Rasmussen J
    JIMD Rep; 2015; 21():79-88. PubMed ID: 25732994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening.
    Koeberl DD; Millington DS; Smith WE; Weavil SD; Muenzer J; McCandless SE; Kishnani PS; McDonald MT; Chaing S; Boney A; Moore E; Frazier DM
    J Inherit Metab Dis; 2003; 26(1):25-35. PubMed ID: 12872837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency.
    Morscher RJ; Grünert SC; Bürer C; Burda P; Suormala T; Fowler B; Baumgartner MR
    Mol Genet Metab; 2012 Apr; 105(4):602-6. PubMed ID: 22264772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cases of 3-methylcrotonyl CoA carboxylase deficiency (3-MCCD) in the California newborn screening program reported in the state database.
    Lam C; Carter JM; Cederbaum SD; Neidich J; Gallant NM; Lorey F; Feuchtbaum L; Wong DA
    Mol Genet Metab; 2013 Dec; 110(4):477-83. PubMed ID: 24103308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.
    Grünert SC; Stucki M; Morscher RJ; Suormala T; Bürer C; Burda P; Christensen E; Ficicioglu C; Herwig J; Kölker S; Möslinger D; Pasquini E; Santer R; Schwab KO; Wilcken B; Fowler B; Yue WW; Baumgartner MR
    Orphanet J Rare Dis; 2012 May; 7():31. PubMed ID: 22642865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of eight novel mutations and transcript analysis of two splicing mutations in Chinese newborns with MCC deficiency.
    Yang L; Yang J; Zhang T; Weng C; Hong F; Tong F; Yang R; Yin X; Yu P; Huang X; Qi M
    Clin Genet; 2015 Nov; 88(5):484-8. PubMed ID: 25382614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of disease spectrum for abnormal 3-hydroxyisovalerylcarnitine metabolism identified through newborn screening and clinical diagnosis].
    Yang Y; Qiu W; Zhang H; Liang L; Lu D; Zhang K; Chen T; Xu F; Gu X; Han L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Dec; 40(12):1466-1471. PubMed ID: 37994125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Methylcrotonyl-CoA carboxylase deficiency: Mutational spectrum derived from comprehensive newborn screening.
    Fonseca H; Azevedo L; Serrano C; Sousa C; Marcão A; Vilarinho L
    Gene; 2016 Dec; 594(2):203-210. PubMed ID: 27601257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.
    Wang T; Ma J; Zhang Q; Gao A; Wang Q; Li H; Xiang J; Wang B
    Front Genet; 2019; 10():1052. PubMed ID: 31737040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acute life-threatening episode of rhabdomyolysis, renal failure, altered mental status and hyperammonemia in an adult with 3-methylcrotonyl-CoA carboxylase deficiency.
    McGowan R; Yano S
    Mol Genet Metab Rep; 2024 Dec; 41():101138. PubMed ID: 39286770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program.
    Rips J; Almashanu S; Mandel H; Josephsberg S; Lerman-Sagie T; Zerem A; Podeh B; Anikster Y; Shaag A; Luder A; Staretz Chacham O; Spiegel R
    J Inherit Metab Dis; 2016 Mar; 39(2):211-7. PubMed ID: 26566957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.